Urapidil Impurity 7 | CAS 20529-23-1 - Request Quote
Urapidil Impurity 7
| SZ CAT No: | SZ-U001007 |
| CAS No | 20529-23-1 |
| Mol.F. | C14H23N3O |
| Mol.Wt. | 249.4 |
| Inv. Status | In Stock |
| Rel. CAT No | SZ-U001025 |
| Rel. CAS No | 129010-86-2 (3HCl salt) |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Urapidil Impurity 7 is chemically 3-[4-(2-Methoxyphenyl)-1-piperazinyl]propylamine. Urapidil Impurity 7 is supplied with detailed characterization data compliant with regulatory guideline. Urapidil Impurity 7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Urapidil .
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 20529-23-1
Purchase 20529-23-1
Order 20529-23-1
Enquire 20529-23-1
price of 20529-23-1
20529-23-1 Supplier
20529-23-1 Manufacturer
20529-23-1 Exporter
buy high quality Urapidil Impurity 7
Purchase Urapidil Impurity 7
Urapidil Impurity 7 suppliers
Urapidil Impurity 7 manufacturers
Urapidil Impurity 7 price
Order Urapidil Impurity 7
Enquire Urapidil Impurity 7
Urapidil Impurity 7 cost
Urapidil Impurity 7 Supplier
Urapidil Impurity 7 Distributor
Urapidil Impurity 7 for Method Validation
Urapidil Reference Standard
Urapidil Impurity 7 for ANDA Filing
Urapidil Impurity 7 for Forced Degradation Studies
Urapidil Impurity 7 Identification Standards
Urapidil Impurity 7 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.